196 results on '"Bordone, A"'
Search Results
2. Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: 1 Year Versus 2 Years
3. Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema
4. TWO-YEAR ANALYSIS OF THE DONIDALORSEN PHASE 2 OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH HEREDITARY ANGIOEDEMA
5. TWO-YEAR ANALYSIS OF DONIDALORSEN TAKEN EVERY 8 WEEKS (Q8W) IN PATIENTS WITH HEREDITARY ANGIOEDEMA
6. Two cases of bullous pemphigoid effectively treated with oral tofacitinib
7. Inborn errors of immunity contribute to the burden of skin disease and create opportunities for improving the practice of dermatology
8. Clinical response to oral tofacitinib in pediatric patients with alopecia areata
9. Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples
10. Effective treatment of alopecia universalis with oral upadacitinib
11. Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation
12. Oral Tofacitinib Effectively Treating Eruptive and Hypertrophic Cutaneous Lichen Planus
13. Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: Updated Interim Analysis With Quality-of-Life Data
14. The Impact of Donidalorsen Taken Every 8 Weeks in Patients With Hereditary Angioedema
15. Two cases of bullous pemphigoid effectively treated with oral tofacitinib
16. Phase 2 Open-Label Extension Study With Donidalorsen Treatment in Patients With Hereditary Angioedema: Pharmacodynamic Data
17. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
18. Oral tofacitinib effectively treating eruptive and hypertrophic eutaneous lichen planus
19. Effective treatment of alopecia universalis with oral upadacitinib
20. Clinical response to oral tofacitinib in pediatric patients with alopecia areata
21. PHASE 2 OPEN-LABEL EXTENSION STUDY WITH DONIDALORSEN TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA
22. Fracture toughness of High-Manganese steels with TWIP/TRIP effects
23. EP11.01-006 Setting Up an Ultra-Fast Next-Generation Sequencing Approach as a Reflex Testing at Diagnosis in Non-squamous Non-small Cell Lung Cancer
24. 567 Gut dysbiosis is associated with the development of alopecia areata
25. Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples
26. Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system
27. Marine monitoring by SCUBA divers reveals new aspects of the temperature variability inside the Gulf of Naples (Tyrrhenian Sea)
28. Tofacitinib Therapy for Alopecia Areata is not Associated with Adverse Events during COVID-19 Infection
29. Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France)
30. Molecular study of hearing loss in Minas Gerais, Brazil
31. The Impact of Donidalorsen Taken Every 8 Weeks in Patients With Hereditary Angioedema
32. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
33. Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: Updated Interim Analysis With Quality-of-Life Data
34. Phase 2 Open-Label Extension Study With Donidalorsen Treatment in Patients With Hereditary Angioedema: Pharmacodynamic Data
35. Expression dynamics of the immune mediators ARG1, TBET, CIITA, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapy
36. The Impact on Quality of Life Following Treatment with Plasma Prekallikrein Targeted Oligonucleotide Antisense Therapy in Hereditary Angioedema Patients
37. Pharmacodynamics and Pharmacokinetics of PKK-LRx in Patients with Hereditary Angioedema
38. An Open-label Trial With Plasma Prekallikrein Oligonucleotide Antisense Therapy To Control Angioedema Attacks In Hereditary Angioedema Patients With Normal C1-inhibitor
39. Alopecia areata after SARS-CoV-2 vaccination
40. Fracture toughness of High-Manganese steels with TWIP/TRIP effects
41. A020 A PHASE 2 STUDY EVALUATING AN ANTISENSE OLIGONUCLEOTIDE TO PREKALLIKREIN IN PATIENTS WITH HEREDITARY ANGIOEDEMA
42. Three loop calculations and inclusive V
43. EP11.01-006 Setting Up an Ultra-Fast Next-Generation Sequencing Approach as a Reflex Testing at Diagnosis in Non-squamous Non-small Cell Lung Cancer
44. 567 Gut dysbiosis is associated with the development of alopecia areata
45. 25580 Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in the United States
46. Marine monitoring by SCUBA divers reveals new aspects of the temperature variability inside the Gulf of Naples (Tyrrhenian Sea)
47. An intertidal life: Combined effects of acidification and winter heatwaves on a coralline alga (Ellisolandia elongata) and its associated invertebrate community
48. Medical comorbidities and sex distribution among patients with lichen planopilaris and frontal fibrosing alopecia: A retrospective cohort study
49. 462 Clinical improvement in primary cicatricial alopecias following mast cell stabilizer treatment
50. Carbonate chemistry and temperature dynamics in an alga dominated habitat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.